Skip to content

CCR7/CCL21 Axis in Regulating CD8+ T Cell-Mediated Immune Microenvironment Remodeling and the Progression of Diabetic Peripheral Neuropathy

CCR7/CCL21 Axis in Regulating CD8+ T Cell-Mediated Immune Microenvironment Remodeling and the Progression of Diabetic Peripheral Neuropathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118962
Enrollment
Unknown
Registered
2026-02-13
Start date
2025-06-01
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic peripheral neuropathy

Interventions

Diabetes peripheral neuropathy group:N/A
Control group:N/A

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diabetic Peripheral Neuropathy Group: Patients with diabetic peripheral neuropathy complicated by lower limb gangrene, in whom debridement and other treatment methods cannot improve the condition and amputation is required. Inclusion criteria: (1) Voluntarily participate and sign the informed consent form; (2) Age >= 18 years; (3) Confirmed diagnosis of type 2 diabetes mellitus; (4) Confirmed diagnosis of diabetic peripheral neuropathy. 2. Control Group: Patients who require amputation due to severe limb, soft tissue, and vascular injuries caused by traffic accidents, in whom surgical reconstruction or repair is not feasible. Inclusion criteria: (1) Voluntarily participate and sign the informed consent form; (2) Age >= 18 years; (3) No history of diabetes mellitus; (4) No history of neurological diseases.

Exclusion criteria

Exclusion criteria: 1. Diabetic Peripheral Neuropathy Group: Exclusion criteria: (1) Severe systemic infectious diseases; (2) Malignant tumors; (3) Pregnancy or lactation; (4) Neuropathy caused by other reasons, such as alcohol, drugs, spinal cord compression, spinal cord inflammation or injury, lumbar disc herniation, etc. 2. Control Group: Exclusion criteria: (1) Severe systemic infectious diseases; (2) Malignant tumors; (3) Pregnancy or lactation; (4) Neuropathy caused by other reasons, such as alcohol, drugs, spinal cord compression, spinal cord inflammation or injury, lumbar disc herniation, etc.

Design outcomes

Primary

MeasureTime frame
Expression of immune cells and inflammatory factors in peripheral blood and peripheral nerve tissue;

Secondary

MeasureTime frame
Expression of chemokines in peripheral blood and peripheral nerve tissue;

Countries

China

Contacts

Public ContactXie Xiaoyun

Shanghai Tenth People's Hospital

xiaoyunxietj@126.com+86 21 66301604

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026